本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Amylyx Pharmaceuticals

31.62
-0.4700-1.46%
盤後31.620.00000.00%19:51 EDT
成交量:171.27萬
成交額:5,472.62萬
市值:39.67億
市盈率:-22.10
高:33.00
開:32.09
低:31.37
收:32.09
52周最高:41.14
52周最低:10.83
股本:1.25億
流通股本:1.10億
量比:1.28
換手率:1.56%
股息:- -
股息率:- -
每股收益(TTM):-1.4309
每股收益(LYR):-1.5305
淨資產收益率:-74.73%
總資產收益率:-44.13%
市淨率:16.59
市盈率(LYR):-20.66

資料載入中...

2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/08

重要事件披露

Form 8-K - Current report
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]